Skip to main content
Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
4.020
+0.060 (1.52%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Precigen Revenue

In the year 2025, Precigen had annual revenue of $9.68M with 146.73% growth. Precigen had revenue of $4.57M in the quarter ending December 31, 2025, with 283.61% growth.

Revenue (ttm)
$9.68M
Revenue Growth
+146.73%
P/S Ratio
146.92
Revenue / Employee
$60,525
Employees
160
Market Cap
1.42B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20259.68M5.76M146.73%
Dec 31, 20243.93M-2.30M-36.95%
Dec 31, 20236.23M-20.68M-76.87%
Dec 31, 202226.91M12.64M88.61%
Dec 31, 202114.27M-17.73M-55.40%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardelyx 407.32M
Immunocore Holdings 400.02M
Iovance Biotherapeutics 263.50M
Viridian Therapeutics 70.85M
Immatics 56.67M
Agios Pharmaceuticals 54.03M
Maze Therapeutics 2.50M
Revenue Rankings

PGEN News

More News